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Abstract
Background: Normal mammary gland contains an extravascular population of B lymphoblasts,
precursors of the immunoglobulin plasma cells that play a key role in the passive protection of
neonates by secreting immunoglobulins to colostrum and milk. We investigated the presence of
chemoattractants in the milk by analysing the chemoattractant activity of various fractions of this
secretion. Milk chemoattractants are potentially involved in the recruitment of lymphocytes from
the maternal bloodstream in lactating mammary glands.
Results: The dilution-related lymphoid cell chemoattraction of whey was associated with a < 10
kDa ultrafiltrate. Active fractions were purified by reverse-phase high performance liquid
chromatography. Two peptides of 2.7 kDa (DMREANYKNSDKYFHARGNYDAA) and 1 kDa
(RPPGLPDKY) were identified as fragments of the SAA protein family, tentatively identified as
SAA2. Only the 2.7 kDa synthetic peptide displayed chemotactic activity, at two different optimal
concentrations. At the lower concentration (3.7 nM), it attracted B-cell lymphoblasts, whereas at
the higher (3.7 μM), it attracted B lymphocytes. Then, the SAA mRNA expression was analysed
and we observed more SAA transcripts during lactation than gestation.
Conclusion: These data are consistent with the SAA23–45 fragment being involved in preplasma B-
cell recruitment to the mammary gland and resultant benefit to the neonate.
Background
The mammary gland (MG) secretion is essential for the
survival of neonatal mammals [1]. This organ is a tertiary
extralymphoid tissue with non-organised lymphoid com-
ponents [1,2]. Its vasculature and epithelium expand in
size during gestation and lactation. In all mammalian spe-
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cies, this gland is colonised by T and B lymphocytes [3-6].
T lymphocytes accumulate in the MG during gestation
whereas B cells and their plasma cell derivatives progres-
sively accumulate during lactation [3,6-8]. Colostrum and
milk immunoglobulins (Igs) are the net result of Ig
extravasation from blood and local Ig production by
plasma cells [9]. These plasma cells are derived from
remote tissue precursors which are induced either in sys-
temic and in mucosal sites, depending on Ig isotype. In
single-stomached animals, IgA is secreted by IgA plasmab-
lasts, which originate in the gut [6,8,10-12] whereas IgG is
derived from systemic sites [13].
It has been shown that the CC chemokine CCL28 [14-16]
plays a major role in IgA plasma cell recruitment. Other
factors may also be involved, particularly for other types
of plasma cell. Indeed, unidentified factors in milk
increase the migration of mouse IgG- and IgA-bearing
mucosal lymphocytes [17]. For example, tumour necrosis
factor isolated from milk has been shown to increase the
migration of lymphocytes [18]. Moreover, other studies
have reported that milk contains factors with cell regula-
tory and stimulatory properties. These factors include hor-
mones and cytokines, which do not have specific effects
on any given lymphocyte subset [19]. We have shown that
swine whey has chemoattractant activity (CA) for swine
lymphocytes [20]. We therefore hypothesized that whey
was involved in the local recruitment of plasma cells
[6,21]. We tested this hypothesis by fractionating sow
milk and assessing the ability of purified fractions to
increase lymphocyte or B lymphoblast migration in rela-
tion to the stage of development of the healthy mammary
gland.
Results
Chemoattractant activity of whey ultrafiltrate
Previous investigations have shown that the removal of fat
and casein did not result in the loss of the original CA of
skimmed milk (data not shown). We show here that the <
10 kDa ultrafiltrate fraction (UF10) gave a bell-shaped
dose-response curve typical of chemoattractants at the
same optimal dilution (1/100), and with a similar
number of migrating cells (Figure 1A to 1C) to unfiltered
whey. On the contrary, the > 10 kDa fraction was inactive
(Figure 1A). Lymph node (LN) lymphocytes (Figure 1B
and 1C) and B lymphoblasts (Figure 1A) migrated to sim-
ilar extents. Neutrophils [22] and monocytes (data not
shown) purified from the swine blood do not exhibit any
CA with fMLP and the < 10 kDa ultrafiltrate fraction.
These results combined with morphological data demon-
strate that CA activity is restricted to lymphoid cells. As CA
was similar for lymphocytes from the mesenteric lymp
node (MLN) and the ileal lymph node (ILN), we subse-
quently evaluated CA principally on B-cell lymphoblasts
and MLN lymphocytes.
RP-HPLC fractionation and purification of the milk 
chemoattractant
In two fractions (F1 and F2) of the first RP-HPLC fraction-
ation of UF10 (Figure 2A-1), CA was recovered at the orig-
inal dilution (1/100), with B lymphoblasts and MLN
lymphocytes, whereas F3 was inactive. After further frac-
tionation, only the F2A and F2B fractions were active (Fig-
ure 2A-2) with both B-cell lymphoblasts and lymphocytes
at optimal and suboptimal dilutions, whereas the F1A
fraction was only active at optimal dilution. We fraction-
ated F2A and F2B further and found that only the F2B1
subfraction was active with both B-cell lymphoblasts and
MLN lymphocytes at optimal and suboptimal concentra-
tions, whereas the F2A1 and F2A2 subfractions were not
active at suboptimal concentrations. The initial CA of
UF10 was recovered mostly in the F2B1 subfraction,
which was subjected to a fourth run of RP-HPLC, (Figure
2A-4). CA with both lymphoblasts (Figure 3) and lym-
phocytes was recovered in the F2B1-A and F2B1-B peaks.
Identification of the chemotactic peptide
The two most chemoattractant peaks, F2B1-A and F2B1-B,
were characterised by MS (Table 1). These peaks were
found to correspond to five peptides with overlapping
sequences. A 3471 Da peptide was found in both the A
and B peaks, whereas the 1042 Da peptide was present in
peak A but not in peak B. The peptides were sequenced by
MS-MS and homology searches of databases (Swissprot)
indicated that all sequenced peptides in peaks A and B
were derived from the same serum amyloid A protein
(SAA), with the exception of an unidentified 3471 Da
peptide.
We assessed if these peptides derived from SAA were
responsible for the CA of the F2B1 fraction, by testing the
CA of the synthetic peptides DMREANYKNSDKYF-
HARGNYDAA (Mr 2735) and RPPGLPDKY (Mr 1042)
separately. These two synthetic peptides eluted with the
same retention times as peaks A and B from F2B1 in RP-
HPLC (Figure 2A-4) under the same conditions (data not
shown). We also showed that F2B1-A induced potent
chemotaxis (Figure 2B).
The dilution-effect curve (Figure 3A) showed that CA was
recovered with the 2.7 kDa peptide, albeit at 1000 times
lower concentrations for lymphoblasts (Figure 3B) than
for MLN lymphocytes (Figure 3B), whereas the 1.0 kDa
peptide had no activity. Furthermore, there were two
peaks of CA with ILN lymphocytes (Figure 3C) at 3.7 μM
and 3.7 nM. At the lower concentration, most of the
migrating cells were lymphoblasts, in clusters of 10 to 25
cells. This result is consistent with the effects on L14 B
lymphoblasts, which was observed at the same concentra-
tion (Figure 3A). At the higher concentration, the 2.7 kDa
peptide induced the migration of small ILN lymphocytes,BMC Immunology 2009, 10:4 http://www.biomedcentral.com/1471-2172/10/4
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Chemoattractant activity of whey with lymphoid cells, before (▲ – ▲) and after 10 kDa PES membrane ultrafiltration (■ – ■) Figure 1
Chemoattractant activity of whey with lymphoid cells, before (▲ – ▲) and after 10 kDa PES membrane ultra-
filtration (■ – ■). Swine B-cell lymphoblasts (A), lymphocytes from the MLN (B) and from the ILN (C). Spontaneous and 
fMLP (10-6 M)-induced migrations are indicated by horizontal lines. In the insert: Absence of chemotactic activity of ultra-reten-
tate onto B lymphoblasts. The results are expressed as the mean number of adherent cells per 4 HPF in 3 independent exper-
iments (except with ILN (n = 6)), each performed in triplicate (*p < 0.05 versus spontaneous migration).
      
Medium
fMLP
0
100
200
300
400
500
Medium
fMLP *
A
Medium
fMLP
0
100
200
300
400
0
Medium
fMLP
B
*
Medium
fMLP
-4 -3 -2 -1 0 1
0
100
200
300
400
0
Medium
fMLP
C
*
Medium
fMLP
-4 -3 -2 -1 0 1
0
100
200
300
Medium
fMLP
C
e
l
l
 
n
u
m
b
e
r
 
p
e
r
 
4
H
P
F
 
(
m
±
 
s
e
m
)
 
  Unfiltered whey or UF-10 Ultrafiltrate (log dilution) BMC Immunology 2009, 10:4 http://www.biomedcentral.com/1471-2172/10/4
Page 4 of 16
(page number not for citation purposes)
Subfractionation of < 10 kDa whey ultrafiltrate by successive RP-HPLC (A, left panel 1 to 4), showing specific chemoattractant  activity (A, medium and right panels) with B-cell lymphoblasts and MLN lymphocytes Figure 2
Subfractionation of < 10 kDa whey ultrafiltrate by successive RP-HPLC (A, left panel 1 to 4), showing specific 
chemoattractant activity (A, medium and right panels) with B-cell lymphoblasts and MLN lymphocytes. Each 
fraction was collected and freeze-dried to remove any residual solvent. Chemoattractant activity was determined at 1/100 
(black) and at 1/1000 (shaded) dilutions of the F1 and F2 fractions. The results are the mean number (± SEM) of specific migrat-
ing cells in independent experiments (* p < 0.05 versus spontaneous migration). Lymphoblast migration towards 2B1 fraction 
and subfractions at a dilution of 1/1000 (B), in the Boyden's chamber assay (Magnitude ×100). F2B1-A fraction and positive 
control (fMLP) induced potent chemotaxis. Nearly only the pores (8 μM) in the filter are seen in spontaneous migration (SM) 
and in F2B1-D fraction.
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consistent with the observed effects on small MLN lym-
phocytes (Figure 3B).
We investigated whether peptides were chemotactic or
chemokinetic, using the checkerboard assay (Table 2)
with B lymphoblasts. Maximal migration occurred when
higher molar concentrations of the 2.7 kDa peptides were
placed in the lower compartment and no significant
increase in migration was observed when equal molar
concentrations of 2.7 kDa peptides were placed on both
sides of the filter, thereby demonstrating that the 2.7 kDa
residue peptide was not chemokinetic. The 1 kDa peptide
did not display any activity potentially attributable to a
chemokinetic or chemotactic response.
Chemoattractant activity with separated CD3+ and sIg+ 
cells from mesenteric lymph node
CD3+ T lymphocytes and sIg+ B cells were purified by
immunomagnetic positive sorting. The enrichment for
CD3 was > 95% and the depletion for sIg > 95% (data not
shown). The migration of CD3+ T cells in response to
UF10 did not differ from spontaneous migration (Figure
4A), whereas the CD3- fraction induced a dose-dependent
increase in migration. Conversely, the extent of migration
of the purified sIg+ B cells (Figure 4B) towards the 2735
Da peptide was higher than that of spontaneous migra-
tion, at a concentration of 3.7 μM (p < 0.01), whereas the
extent of migration of the sIg- fraction did not differ (p >
0.05) from that of spontaneous migration. No increase in
migration towards the 1042 Da peptide was (p > 0.05)
observed in either sIg+ B cells or sIg-depleted cells. Conse-
quently, the 2735 Da peptide is chemoattractant for swine
sIg+ B cells, but not for CD3+ T cells. Furthermore, the
peptide was not chemoattractant for purified porcine neu-
trophils and monocytes (data not shown).
SAA mRNA production in the porcine mammary gland
We then assessed porcine SAA mRNA expression in the
MG as a function of developmental stage. MG cDNA was
amplified by PCR using primers (F0 and R0) designed
into two relatively well conserved SAA regions. A single
PCR product, corresponding to an internal fragment of
the porcine SAA cDNA, was obtained (Figure 5). Its
deduced amino-acid sequence carried the signature of all
serum amyloid A proteins: ARGNYD(E)A-K(Q, R)RG-GG-
WA. Moreover, this sequence showed a very high percent-
age of amino acids identical to those of the SAA2
sequences of Sus scrofa [GenBank:ABC96790] now availa-
ble (Figure 6). As a single sequence was amplified by PCR,
this "SAA2" is probably the most predominant member of
the SAA family expressed in the MG. Production of the
porcine SAA mRNA in MG was then assessed, using a sec-
ond primer pair (F1 and R1) designed on the basis of our
porcine SAA cDNA sequence. In porcine MG, SAA mRNA
was detectable during gestation, and its level began to
Chemoattractant activity of 1042 Da () and 2735 Da (▲)  synthetic peptides with B-cell lymphoblasts (3A); lym- phocytes from MLN (3B); and from ILN (3C) Figure 3
Chemoattractant activity of 1042 Da () and 2735 
Da (▲) synthetic peptides with B-cell lymphoblasts 
(3A); lymphocytes from MLN (3B); and from ILN 
(3C). The results are expressed as the mean number (± 
SEM) of specific migrating cells per 4 HPF in independent 
experiments (A, n = 1; B, n = 4; C, n = 2).
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increase significantly at day 80 of gestation, reaching a
peak at day 15 of lactation (Figure 5). The SAA mRNA
expression was higher in the second half of lactation than
at any stage of gestation (p < 0.05).
Peptide-induced mobilization of intracellular Ca++ in 
differentiated HL-60 cells and FPRL2-expressing HL-60 
cells
Because the 2.7 kDa peptide (DMREANYKNSDKYF-
HARGNYDAA) exhibits a high degree of amino acid iden-
tity with human SAA, which previously has been shown to
bind to and to activate the human N-formyl peptide
receptor-like 1 (FPRL1), we tested whether it could acti-
vate a FPRL1- or FPRL2-dependent calcium response.
FPRL1 is a member of the FPR family that is expressed in
human neutrophils and differentiated HL-60 cells as well
as monocytes, whereas the N-formyl peptide receptor-like
2 (FPRL2) is expressed in human monocytes but not in
neutrophils. When added to differentiated HL-60 cells or
undifferentiated FPRL2-expressing HL-60 cells, the 2.7
kDa synthetic peptide (DMREANYKNSDKYFHARGNY-
DAA) was unable to induce intracellular calcium mobili-
Table 1: Tandem mass spectrometry sequences of A and B peaks peptides of the 2B1 fraction obtained from the < 10 kDa fraction 
after 4 RP-HPLC runs. 1 In italic, sequences of synthetic peptides.
AA sequence Theoretical mass (Da) Measured mass (Da)
Peak A
DMREANYKNSDKYFHARGNYDAA1 2735.21 2734.55
RPPGLPDKY 1041.56 1041.30
SDMREANYKNSDKYFHARGNYDAA 2822.25 2821.57
Not identified 3470.92
DMREANYKNSDKYFHARGNYDA 2664.18 2663.52
Peak B
DMREANYKNSDKYFHA 1987.88 1987.82
YSDMREANYKNSDKYFHARGNYDAA 2985.31 2985.27
Not identified 3471.77
DMREANYKNSDKYFHARGNYDAA 2735.21 2735.18
YSDMREANYKNSDKYFHARGNYDA 2914.27 2914.26
Table 2: Checkerboard assay of lymphoblast migrationa towards 2.7 and 1 kDa peptides.
Concentration of the 2.7 kDa peptide (nM) above the filter
Concentration of the 2.7 kDa peptide (nM) below the filter 0 3.7 37 370
01 0 0 . 3 b ± 11.2 148.6 ± 14.2c 77.6 ± 1.7c 136.0 ± 9.8c
3.7 224.3 ± 2.0c 132.0 ± 8.0 114.7 ± 0.3c 156.5 ± 7.5
37 228.0 ± 12.7c 125.5 ± 13.5 146.0 ± 11.0 125.0 ± 12.0
370 119.0 ± 8.7 87.6 ± 3.2c 110.5 ± 0.5 74.3 ± 4.1
Concentration of the 1 kDa peptide (nM) above the filter
Concentration of the 1 kDa peptide (nM) below the filter 0 3.7 37 370
01 0 3 b.0 ± 5.2 103.3 ± 16.8c 124.7 ± 8.9 124.6 ± 9.5
3.7 49.0 ± 4.0 70.7 ± 4.2 85 ± 13.3 121.3 ± 39.6
37 64.0 ± 43.1 66.3 ± 8.9 60.7 ± 3.2 147.3 ± 6.8
370 64.3 ± 6.1c 49.0 ± 2.9c 74.7 ± 11.6c 103.3 ± 4.41
aMigration was assessed with B lymphoblasts after 1 h of incubation in the presence of peptides in the upper, lower or both compartments. For 
underlined values, there was no gradient of peptide concentration between the upper and the lower compartments. In each column, above the 
underlined values, the peptide concentrations were lower than in the upper compartment and below the underlined values, the peptide 
concentrations were higher than in the upper compartment. Results are means ± SEM of migrating cells, for experiments carried out in triplicate. 
bSpontaneous migration in the absence of peptide. cSignificant difference between migration in the absence of a gradient (underlined values) and 
peptide-induced migration (p < 0.05 by Student's t test). A polycarbonate filter with 12 μm pores separated the two compartments of the chamber.BMC Immunology 2009, 10:4 http://www.biomedcentral.com/1471-2172/10/4
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Chemoattractant activity of < 10 kDa fraction (A) and of synthetic peptides (B) with MLN lymphocytes enriched in CD3 or  depleted in SIg+ B cells (at a concentration of 3.7 μM) Figure 4
Chemoattractant activity of < 10 kDa fraction (A) and of synthetic peptides (B) with MLN lymphocytes 
enriched in CD3 or depleted in SIg+ B cells (at a concentration of 3.7 μM). A) CD3+ (F+), CD3- (F-) and origin cell 
(FO) fractions with the < 10 kDa fraction of whey (UF10) and corresponding spontaneous migration (fMLP 10-6 M) and RPMI 
controls with FO, F+ and F-). B) Chemoattractant activity of 1042 Da (PepA) or 2735 Da (PepB) synthetic peptide with the 
SIg+ B cell-enriched fraction (F sIg+) and chemoattractant activity of the same 1042 Da (PepA) and 2735 Da (PepB) peptides 
with the fraction depleted of SIg+ B cells (F sIg-). Corresponding spontaneous migration (fMLP 10-6 M and RPMI controls). 
Results are the mean number of adherent cells ± SEM per 4 high-power fields (HPF).
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Expression of SAA in the mammary gland during gestation and lactation, as determined by semi-quantitative reverse transcrip- tion-polymerase chain reaction (RT-PCR) Figure 5
Expression of SAA in the mammary gland during gestation and lactation, as determined by semi-quantitative 
reverse transcription-polymerase chain reaction (RT-PCR). Upper panel: Profiles of bands obtained for SAA and 
cyclophilin in porcine MG. Lower panel: Kinetics of SAA mRNA production from the virgin state through gestation and lacta-
tion in porcine MG. The relative signal intensities were obtained by normalization with respect to the cyclophilin signal (mean 
± SEM of 2–3 animals). (*) Levels of SAA mRNA did not vary during gestation or lactation, until day-80 of gestation, after which 
they increased significantly, reaching a peak on day 15 of lactation L15: p < 0.05 in Student's t tests.
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zation. In contrast, recombinant human ApoSAA, an
agonist specific of FPRL1, or WKYMVm, an agonist of
FPRL2, triggered a robust calcium response in differenti-
ated HL-60 cells or undifferentiated FPRL2-expressing
cells, respectively. This observation indicates that the
absence of response with B cells could not be due to a lack
of expression of FPRL1 (Figure 7A) or FPRL2 (Figure 7B).
Discussion
In this study, most of the CA of milk for B lymphocytes
and B lymphoblasts was detected with the 2735 Da pep-
tide isolated from the whey while no CA activity was
detected in the 1042 Da peptide from the same fraction.
CA activity was not detected for neutrophils and mono-
cytes, either onto filter or with purified blood cells.
Amino-acid sequencing of the two peptides showed that
they belonged to the SAA protein family [23]. The partial
sequence of the SAA cDNA amplified from the MG sug-
gested that these peptides might be derived from SAA2, as
the DNA sequence obtained was 98% identical to that of
porcine SAA2 [24]. However, we cannot draw definitive
conclusions concerning the SAA subtype corresponding to
the 2.7 kDA chemoattractant peptide, as this peptide dis-
played a high degree of identity (> 90%) with SAA sub-
types from different origins. Our data suggesting that
SAA2 predominates in the MG, are reminiscent of the
finding that bovine mammary-SAA or SAA3 differs from
serum-AA in being present at extrahepatic sites, such as
the gut epithelium, MG epithelium [25] and in colostrum
and milk in healthy animals [26]. However, human breast
was found to contain SAA1, SAA2 and SAA4, indicating
that there is considerable variation amongst species,
despite the sequence similarities. In swine SAA2, there is
no deletion of the 8 aa (number 88 to 95) of the human
sequence required for acute inflammation reaction [27].
This observation provides further evidence that this pep-
tide could play a physiological role in normal MG. The
catabolic pathway of SAA has yet to be completely
defined, but various studies have suggested that SAA is
degraded by cell-associated elastase-like proteases [28,29]
and several other serine proteases found in serum and
milk, including kallikrein and plasmin [30-32]. The pro-
teolysis of SAA by these enzymes leads to the generation
of specific peptide fragments, some corresponding to
amino acids 29 to 42 of SAA sequence, whereas the chem-
oattractant peptide is longer (23–45) and has different
cleavage sites. The specific action of the mammary SAA
peptide on B lymphoid cells contrasts with the previously
described activity of SAA. Indeed human SAA is described
as involved in adhesion induction, migration, and tissue
infiltration of T lymphocytes [33]. The 2.7 kDa peptide
(DMREANYKNSDKYFHARGNYDAA) is 92.3% identical
to the 29–42 peptide of hSAA-A (YIGSDKYFHARGNY)
[34], suggesting a similar function. However, only a few
studies have used synthetic peptides: One study reported
that hSAA29–42 inhibited adhesion [34], whereas another
found no inhibitory effect on neutrophil migration [35].
It has been shown that hSAA and the 29–42 fragment dis-
play agonist activity involving FPRL1 receptor [36,37].
Moreover, fMLP receptor has not only been described on
human neutrophils and NK cells but also on B cells
[38,39]. As in our study, the fact that B cells respond to
μmolar concentrations suggest that they exhibit FPRL1 or
FPRL2 receptors. However, we may exclude FPRL2 as this
receptor does not bind or respond to N-formyl peptides
[38]. On the other hand, swine L14 B cells incubated with
human apoSAA or swine 2.7 kDa peptide failed to exhibit
any calcium flux. These results indicate that the peptide
probably uses a receptor other than FPRL1 and FPRL2.
This receptor could be the recently described "receptor
independent of FPRL1 [40], which did not lead to a cal-
Comparison of the SAA sequence recovered from the porcine mammary gland (Porcine SAAF0-R0) with sequences of SAA2  isoforms Figure 6
Comparison of the SAA sequence recovered from the porcine mammary gland (Porcine SAAF0-R0) with 
sequences of SAA2 isoforms. Sequences were obtained from the NCBI website http://www.ncbi.nlm.nih.gov/entrez/
query.fcgi?db=Protein, for swine (ABC96790), mink (P02739), hamster (P20727), human (AAH20795), rabbit (P22000) and 
mouse (AAH24606). Amino-acid position is indicated at the top of the figure and corresponds to the amino-acid number in the 
Porcine SAA2 sequence (ABC96790). Identical and conservative residues are highlighted in dark and light grey, respectively. 
Gaps are denoted by a dash. The sequences of the peptides obtained from whey and synthesised in this study are underlined.
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Porcine SAA2     YSDMREANYKNS DKYFHARGNYDAAQRGPGGAWAAKVISDARENVQRVTDLFKHGDSGHGVE DSRADQAANAWGRSGKDPNHFRPRGLPDKY 
Mink SAA2        YSDMREANYKNS DKYFHARGNYDAAQRGPGGAWAAKVISDARERSQRVTDLFKYGDSGHGVE DSKADQAANEWGRSGKDPNHFRPSGLPDKY 
Hamster SAA2     YTDMREANWKNS DKYFHARGNYDAAQRGPGGAWAAKVISDAREGFKRMR--------GRGIE DSRADQFANEWGRSGKDPNFFRPPGLPSKY 
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cium influx. Furthermore, this receptor could be present
in two similar forms: One of lower avidity on B cells and
the other of higher avidity or subject to up-regulation after
the activation of B cells or B lymphoblasts. Alternatively,
these results could fit with the observation that B lym-
phocytes can respond without mobilization of intracellu-
lar calcium as observed, for example, with chemokines
CCL19, CCL21, CXCL12 and CXCL13 [41]. The lack of CA
of the terminal SAA peptide (RPPGLPDKY) with B cells
does not entirely rule out activity with these cells. Indeed,
the truncated form of hSAA, AGLPDKY (SAA98–104), and
analogues are known to bind human CD4+ T lym-
phocytes and to stimulate them to produce interferon-γ. It
is also possible that the 98–104 peptide makes the cells
susceptible to the 29–42 fragment chemoattraction after
activation.
Binding may also lead to the induction of cellular
responses, such as cytokine secretion [42] and the up-reg-
ulation of integrin α4β1, in particular. α4β1 expression
increases the probability of in vivo binding to VCAM-1
[43], a vascular addressin present on the MG blood vessels
[6]. The lymphocyte aggregation observed in the present
study (Figure 2B) would be consistent with the expected
effect of such binding.
The YIGSD laminin-like element of hSAA is replaced by
the YKNSD element in pSAA, and both hSAA and pSAA
express RGN motif, a "RGD like" motif. This RGN motif
[34] represents integrin-binding and cell attachment
motifs derived from cellular adhesion protein molecules,
such as fibronectin, collagen, vitronectin, fibrinogen, lam-
inin and many microbial proteins, including the Tat pro-
tein of the human immunodeficiency virus [44,45].
Binding of the RGN motif to the cell membrane is known
to stimulate membrane integrins, leading to a local
increase in the concentrations of F-actin and α-actinin,
resulting in cell locomotion [46]. It is possible that the
peptide adheres to the filter via this RGN motif, inducing
lymphocyte migration. Transposed in vivo, these data sug-
gest a similar phenomenon, in which the binding of SAA
to the surface of the mammary endothelial cells may
induce B-cell adhesion followed by the transendothelial
migration of these cells in an SAA-peptide gradient.
Finally, in addition to binding to endothelial cells, SAA
also binds to the basal membrane and extracellular
matrix, probably due to its heparin-binding properties
[47]. Thus, gradients of extracellular tissue-bound SAA or
SAA peptides, including the 2.7 kDa peptide, may induce
haptotactic B-cell migration in the mammary tissue dur-
ing lactation.
SAA mRNA and protein productions have been recently
demonstrated in extrahepatic tissues, and specifically in
MG, mostly in epithelial and endothelial cells [25], sup-
Calcium mobilization in myeloid cells expressing FPR, FPRL1  or FPRL2 Figure 7
Calcium mobilization in myeloid cells expressing 
FPR, FPRL1 or FPRL2. Differentiated HL-60 cells and 
undifferentiated FPRL2-expressing HL-60 cells were loaded 
with 2 μM Fura-2 and analyzed with respect to calcium mobi-
lization mediated by the addition of peptides. (A) Addition of 
the 2,7 kDa fragment from SAA2 (1 μM) to differentiated 
HL-60 cells was unable to mobilize intracellular calcium 
whereas 100 nM of recombinant of human ApoSAA, an ago-
nist of FPRL1, induced a robust calcium rise (B) Undifferenti-
ated HL-60 cells that stably express FPRL2 were unable to 
mobilize intracellular calcium in response to the addition of 1 
μM of the 2,7 kDa fragment from SAA2 whereas a calcium 
rise was observed upon addition of 100 nM of WKYMVm, an 
agonist of FPRL2.BMC Immunology 2009, 10:4 http://www.biomedcentral.com/1471-2172/10/4
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porting the hypothesis of a role in lymphocyte recruit-
ment. High extrahepatic expressions and the secretion of
the mammary-associated serum amyloid A 3 isoform (M-
SAA3) in the colostrum and milk of healthy animals has
been reported [26]. Although the functional significance
of extrahepatic SAA production remains unclear, it has
been suggested that the apparent constitutive production
of the SAA transcript in non-hepatic cell lines is consistent
with a housekeeping role for the protein [48], either as a
first line of defence or in the maintenance of tissue func-
tion.
Previous findings of the upregulation of SAA gene expres-
sion in response to prolactin [49] and the increase in B
lymphoblast numbers in the MG during lactation [6,21]
would together be consistent with the results of the
present study. The human MG produces and releases bio-
active prolactin in situ [50]. In this study, we showed that
porcine SAA mRNA production increased during lacta-
tion, consistent with the hormonal regulation of SAA pro-
duction mediated by an increase in prolactin
concentration at this stage of MG development. This milk
peptide, due to its small size, could cross the neonatal gut
epithelium and stimulate the neonatal gut immune
response by enhancing the recruitment of mucosal gut B
lymphoblasts.
Conclusion
In the current paper, we have investigated whether physi-
ological chemoattractants induced the recruitment of
immune cells from the maternal bloodstream in lactating
mammary glands, by analysing the chemoattractant activ-
ity of various milk fractions. The B cell chemoattractant
activity of a SAA 2.7 kDa peptide and the concomitant up-
regulation of SAA mRNA during lactation are consistent
with the SAA23–45 fragment being involved in preplasma
B-cell recruitment to the mammary gland, potentially
influencing Ig concentrations, conferring active and pas-
sive protection on neonates and providing local protec-
tion for the mammary gland.
Methods
Cell isolation and culture
Cryopreserved cells from the swine L14 lymphoblastoid
cell line (ECACC number 91012317) [51] were cultured
and harvested in the exponential growth phase, as previ-
ously described [20,52]. L14 cells is a permanent swine
lymphoblastoïd cell line which has been cloned and con-
firmed to be of B cell lineage [51-54]. In contrast to mono-
cytes, neutrophils, T cells, NK cells and null cells the L14
cells are sWC1- as the B cells [55]. In addition they are Ig
light-chain λ+ (46%), IgM+ (37.5% to 82%), IgA-, IgG-,
cytoplasmic light-chain+ (10%), cytoplasmic IgM+ (7%),
Ig CD1- [51], CD5- (B2 lymphocytes), CD45+, CD45RA+
(Naïves, 40%), CD45RC+ (35 to 80%), CD29+ (β1, 50%
to 80%), CD62L+ (15%), CD11b-, CD11c-, Fc gamma-,
CD40+ (100%, responsible of isotopic commutation),
CD79b+ (pre-B-cells and mature-B-cells, 40%), CD18-,
CD21-, CD49d-, CD49e+ (100%), α4β7-, class II+ (DR
and DQ, 99%). Furthermore, L14 B cells are chemoat-
tracted by CCL28 and expressed the corresponding recep-
tor, CCR10 [13].
Lymphocytes were isolated from mini-pig (SLAd/d) MLN
and ILN and cryopreserved as previously described [56].
Immediately before the test, the cells were cultured over-
night at 37°C in a six-well tissue culture plate (Costar,
Bethesda, MD, USA), in the presence of 5% CO2, at a den-
sity of 106 cells/ml, in RPMI 1640 (Gibco, Cergy-Pontoise,
France) supplemented with 2 mM L-glutamine (Sigma-
Aldrich, Saint-Quentin, France), 1 mM pyruvate (Sigma-
Aldrich, Saint-Quentin, France), and 50 μM  β-mercap-
toethanol (Sigma-Aldrich, Saint-Quentin, France), to
obtain cells with a membrane integrity > 95%, as deter-
mined by Trypan blue exclusion. At the end of the incuba-
tion period, both plastic-adherent and non-adherent cells
were collected. The dead cells were eliminated by gradient
centrifugation (d = 1.09) and the viable cells were sus-
pended in RPMI 1640 medium (Gibco, Cergy-Pontoise,
France) without foetal bovine serum for chemoattractant
assays.
Magnetic cell sorting of CD3+ and sIg+ B lymphocytes
We resuspended 200 × 106 MLN lymphocytes in PBS with-
out Ca2+ or Mg2+, and incubated them with swine serum
for 5 min at room temperature to block the Fc receptors.
They were then washed twice in PBS without Ca2+ and
Mg2+. Cells were incubated on a shaker for 30 min at 4°C
with monoclonal mouse anti-CD3 (BB238 E6) or anti-
swine Ig λ light chain antibody [57]. We then added 200
μl of anti-mouse immunoglobulin magnetic microbeads
(Miltenyl Biotec, Aurburn, CA, USA) to 108 cells in 800 μl
of buffer and the mixture was incubated on a shaker for 30
min at 4°C. The cells were then washed twice with PBS
without Ca2+ or Mg2+ and resuspended in 500 μl of the
same buffer. The cells and beads were loaded onto col-
umns (LST, Miltenyl Biotec, Auburn, CA, USA), which
were placed on a MidiMACS separator. The cells not
bound to the magnetic beads flowed through readily. The
columns were washed with MACS medium (PBS without
Ca2+ or Mg2+ supplemented with 1 mg/ml bovine serum
albumin and 2 mM EDTA). Then, the columns were
removed from the separation unit and filled with MACS
media. A plunger was inserted into the columns to flush
out the CD3+ T cells or Ig light chain-positive cells. The
purity of the positive and negative cells was assessed by
FACS analysis.BMC Immunology 2009, 10:4 http://www.biomedcentral.com/1471-2172/10/4
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Flow cytometry analysis
Cell suspensions in V-bottomed microtitre plates were
immunostained as follow: 5 × 105 cells per well were
washed with 200 μl flow cytometry medium (FCM, 1%
BSA and 0.1% sodium azide in PBS) and incubated with
50 μl goat serum for 5 min at room temperature, to block
non-specific binding. Cells were washed three times in
FCM and incubated for 30 min with 50 μl of mouse anti-
CD3 antibody or mouse anti-swine Ig λ light chain anti-
body with gentle stirring at 4°C in the dark. Then, they
were washed and incubated with 50 μl of goat anti-mouse
IgG RPE (DAKO R 0480, Glostrup, Denmark). Finally,
cells were resuspended in 100 μl FCM and analysed on a
Becton-Dickinson FACScan [58,59].
Chemotaxis assay
Cell chemoattraction was measured in 48-well microtaxis
chambers (Neuroprobe, Cabin John, MD, USA) as previ-
ously described [56]. Briefly, the lower compartment was
filled with 28 μl of chemoattractant solution, using fMLP
10-6 M (Sigma-Aldrich F-3506, lot 48f5805, Saint-Quen-
tin, France) as the positive and medium only (RPMI 1640
without FCS) as the negative control. It has been shown
previously that fMLP is not chemoattractant in swine for
neutrophils [22] but for lymphocytes [56]. Moreover, in
human, fMLP chemoattracted specifically B cells but not T
lymphocytes [60] and recently its receptor has been found
onto B cells and NK cells [39]. We then transferred 48 μl
of cell suspension at a density of 4 × 106cells/ml to the
upper compartment and 25 μl of medium with or without
CA were placed in the lower compartment. The upper and
lower compartments were separated by a polycarbonate
PVP-free membrane with 8 μm or 12 μm pores for lym-
phocytes and lymphoblasts, respectively. Chambers were
incubated for 1 h at 37°C and the filter was then removed
and stained with haematoxylin [56]. Migration was
assessed by counting the number of lymphocytes that had
migrated through the pores and adhered to the lower sur-
face of the filter in four randomly chosen high-power
fields, using a 40× oil objective and a 10× eyepiece with a
Sony 3CCD colour video camera (Sony, Olympus, Japan)
and AnalySIS software (Soft Imaging System, Olympus,
Japan). All samples were tested in triplicate. Specific
migration was evaluated in some experiments.
We investigated whether synthetic peptides of SAA were
chemokinetic (enhanced random migration) or chemo-
tactic (directed migration) by carrying out a checkerboard
assay as previously described [61].
Milk sampling
Milk was obtained five days into lactation, from healthy
control animals at the INRA farm (St Gilles, France). No
evidence of clinical mastitis was found at the time of sam-
ple collection or during the two-month follow-up period.
The milk was skimmed by centrifugation at 2000 g for 15
min at 4°C and caseins were removed by ultracentrifuga-
tion at 85000 g for 1 h at 4°C. The separated fat, whey and
casein fractions were stored at -20°C until further analy-
sis. Our previous data show that these processes do not
result in the loss of the original CA of the skimmed milk.
Ultrafiltration of whey
Whey proteins were subjected to ultrafiltration through
centrifugal concentrators (Vivaspin 20, Sartorius AG,
Goettingen, Germany) at 3000 g and at room tempera-
ture, using a 30 kDa polyethersulfone membrane (UF30)
and then a 10 kDa polyethersulfone (UF10) membrane.
The ultrafiltrates obtained by separation with membranes
of different thresholds were reconstituted to their initial
volume with PBS and tested for CA. Salts and milk sugars
were eliminated by solid-phase extraction (SPE) with a
C18 grafted silica phase. The retained molecules were
washed with 0.1% TFA to remove salts and milk sugar and
then eluted from the silica with an aqueous acetonitrile
solution (80%), and freeze-dried.
Fractionation of ultrafiltrate
Ultrafiltrate UF10 was fractionated by semi-preparative
RP-HPLC on a Vydac C18 column (218TP510, 150 × 10
mm I.D). The column was equilibrated in 100% solvent A
(1.06‰ TFA in milliQ water). Ultrafiltrate UF10 (500 μl)
was injected and after 5 min at 5 ml/min in isocratic
mode, elution was carried out with a linear gradient
increasing to 70% solvent B (1.0‰ TFA in 80% aqueous
acetonitrile) over 40 min. The column temperature was
40°C and elution was monitored at 214 nm. A sequential
subfractionation of UF10 (Figure 2A) was carried out to
isolate the chemoattractant factor, and we focused on the
most chemoattractant fraction at each step. All fractions
were freeze-dried and then resuspended in the same vol-
ume of RPMI as of sample initially injected in RP-HPLC,
for CA evaluation. Three fractions (F1, F2 and F3) were
initially obtained. The F1 and F2 fractions were further
subdivided, by injection of a second aliquot of UF10,
leading to harvesting of the F1A, F1B, F1C, F2A and F2B
subfractions. As CA was highest in the F2A and F2B frac-
tions, these fractions were further subfractionated to give
F2A1, F2A2, F2B1, F2B2 and F2B3. In the last step of RP-
HPLC purification, the F2B1 fraction was further fraction-
ated to give F2B1- A, B, C and D.
Mass spectrometry and tandem mass spectrometry 
analysis of chemoattractant factor
Mass spectrometry measurements were performed at the
research support facility "Plant Biopolymers – Interac-
tions – Structural Biology", INRA, at Nantes. Mass data
analyses were conducted on a hybrid quadrupole orthog-
onal acceleration time-of-flight mass spectrometer (Q-BMC Immunology 2009, 10:4 http://www.biomedcentral.com/1471-2172/10/4
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TOF Global, Waters, Guyancourt, France) equipped with
a nano-flow ESI interface.
For mass analyses, samples were dissolved in 8 μl of a
water:acetonitrile:formic acid mixture (49.5:49.5:1, v/v).
Approximately 1 μl of sample was introduced into a nano-
ESI precoated borosilicate capillary (MDS Proteomics
Inc., Odense, Denmark) and infused into the ion source at
a flow rate of about 50 nl/min. MS and MS/MS measure-
ments were carried out under the control of Mass Lynx
software (Waters, Guyancourt, France).
Synthetic peptides
Two peptides were synthesized at Neosystem SA (Neosys-
tem SA, Strasbourg, France), with the amino-acid
sequences RPPGLPDKY (Mr 1041.56 Da) and DMREAN-
YKNSDKYFHARGNYDAA (Mr 2735.21 Da). Purity
exceeded 98%, as determined by high performance liquid
chromatography (Neosystem SA, Strasbourg, France).
RNA extraction and DNase treatment
Samples of porcine MG tissue (0.1–0.2 g) were collected
into 1 ml Trizol (Invitrogen, Cergy Pontoise, France) in
polypropylene tubes and total RNA was extracted accord-
ing to the manufacturer's recommendations. After isopro-
panol precipitation, the RNA pellet was washed with 75%
ethanol, dried and resuspended in 84 μl of ultrapure water
containing 0.2% (w/vol) diethylpyrocarbonate (Sigma-
Aldrich, Saint-Quentin, France). Possible DNA contami-
nation was eliminated by DNase treatment (Promega
France, Charbonnières, France) for 30 min at 37°C, in a
final volume of 100 μl containing: 4 U RQ1 RNase-free
DNase, 40 U RNasin ribonuclease inhibitor (Promega
France, Charbonnières, France), 1 × RQ1 DNase buffer
(Promega France, Charbonnières, France). We added 1 μl
Stop Solution and incubated the mixture at 65°C for 10
min. RNA was quantified by determining absorbance at
260 nm and purity was assessed by determining the A260/
A280 ratio.
Reverse transcription
Reverse transcription was performed in an iCycler ther-
mocycler (Bio-Rad, Hercules, CA), using 0.2 ml thin-
walled tubes (Applied Biosystems, Foster City, CA, USA).
RNA (5 μg) was first incubated at 65°C for 10 min with
0.5 μg oligodT(12–18) (Invitrogen, Cergy Pontoise, France),
and reverse transcription was then initiated by adding 5 U
AMV reverse transcriptase (Promega France, Charbon-
nières, France), 32 U RNasin (Promega France, Charbon-
nières, France), 1 mM each dNTP (Promega France,
Charbonnières, France) and 1× AMV reverse transcriptase
buffer, in a final volume of 40 μl. The reaction was
allowed to proceed for 1 h at 42°C and cDNA was stored
at -20°C.
PCR amplification of porcine SAA in mammary gland and 
densitometric quantification
We carried out a BLASTN search of the GenBank dbEST
database. As no homologous porcine EST was identified
based on the porcine SAA cDNA sequence, primers F0 et
R0 were designed from dog, mink, guinea pig, rabbit and
human SAA cDNA sequences, CM59173, in a region rela-
tively well conserved between SAA of different subtypes
and different animal origins, using VectorNTI software
(Invitrogen, Cergy Pontoise, France). The forward degen-
erate primer was F0 (5'-TCAAGGGGCTTGGGACATG-3')
and the reverse degenerate primer was R0 (5'-AGGGCA-
GAGCCAAGAGGAAG-3'), yielding a PCR product of 330
bp. PCR amplification was performed using the Pfu DNA
polymerase (Promega France, Charbonnières, France).
PCR was carried out for SAA cDNA amplification, in a
total volume of 20 μl containing 100 ng of cDNA, 1 U Taq
polymerase (Promega France, Charbonnières, France), 0.2
mM of each dNTP, 0.5 μM of each primers, 1× Taq
polymerase buffer (Promega France, Charbonnières,
France), 2 mM MgCl2 (Promega France, Charbonnières,
France). Sense F1 (5'- TCTGACATGAGAGAGGCCAAC-
TAC-3') and anti-sense R1 (5'-GTCAGGCAGGCCACGAG-
GTCT-3') primers were designed on the basis of our
porcine SAA cDNA sequence obtained from the F0-R0
PCR product. The porcine cyclophilin gene was used as a
constitutively expressed 'housekeeping' gene control, to
determine the uniformity of the reverse transcription reac-
tions. Primers were used as previously described [59]. The
amplification conditions were carefully chosen to obtain
signals in the linear range of amplification. Amplification
products (10 μl) were loaded onto a 2% TBE agarose gel
stained with ethidium bromide (0.01%), subjected to
electrophoresis and visualised under a UV transillumina-
tor. The fluorescence intensity of the bands was deter-
mined using the Alpha Imager Gel Analysis System
Fluorchem version 2.00 (Alpha Innotech Corporation,
San Leandro, CA, USA). A single PCR product, of 270 bp
for porcine SAA and 369 bp for cyclophilin, was obtained
and analyzed by DNA sequencing.
Culture and differentiation of HL-60 cells and stable 
expression of N-formyl peptide receptor-like 2 in 
undifferentiated HL-60 cells
Promyelocytic HL-60 cells were cultured in RPMI 1640
medium/glutaMax I supplemented with 10% of heat inac-
tivated foetal calf serum. The maximal density was main-
tained below 2 × 106 cells/ml and, at each passage, cells
were centrifuged and resuspended in an appropriate vol-
ume of complete medium in order to reach a density of 2
× 105 cells per ml. To trigger the expression of both N-
formyl peptide receptor (FPR) and N-formyl peptide
receptor-like 1, HL-60 cells were differentiated to a neu-
trophil-like phenotype by adding N6, O-2'-dibutyryl ade-BMC Immunology 2009, 10:4 http://www.biomedcentral.com/1471-2172/10/4
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nosine 3',5' cyclic monophosphate (Bt2cAMP) at the final
concentration of 1 mM for 3 days. The stable expression
of FPRL2 in undifferentiated HL-60 cells has been previ-
ously described [62].
Determination of changes in cytosolic calcium in 
differentiated HL-60 cells and undifferentiated FPRL2 
expressing HL-60 cells
Cells were washed with PBS and the cell pellets were sus-
pended, at a density of 2 × 107 cells/ml, in RPMI medium
without phenol red containing 0.1% BSA. Cells were sup-
plemented with Fura 2-AM (Molecular Probes, Eugene,
OR, USA) at a final concentration of 2 μM for 30 min, at
37°C. Cell suspensions were then diluted with two vol-
umes of the same medium without BSA, washed once in
10 ml of Ringer-Krebs buffer, and suspended in RPMI
medium without phenol red at a density of 2 × 107 cells/
ml. Calcium measurements were carried out with a SPEX
FluoroMAX fluorescence spectrophotometer with excita-
tion wavelengths of 340 and 380 nm (the ratio 340/380 is
calculated when the signal is weak), an emission wave-
length of 505 nm and slit widths of 5 and 10 nm, respec-
tively. Intracellular free calcium concentrations were
calculated using the following formula: (Ca2+)i = KD(F-
Fmin)/(Fmax-F) with a KD for Fura-2 of 224 nM; Fmax is the
fluorescence in the presence of 0.04% Triton X-100 and
Fmin the fluorescence obtained after addition of 5 mM
EGTA plus 30 mM Tris-HCl, pH 7.4.
Expression of results and statistical analysis
The results of migration assays are expressed in each
experiment as the mean number of migrating lym-
phocytes ± SEM of triplicates. Specific migration was cal-
culated as the difference between the mean number of
lymphocytes migrating in the presence of chemoattractant
and the mean number migrating in the control medium
(i.e. undergoing spontaneous migration). SAA mRNA lev-
els are presented as the mean ± SEM of the ratio of the
band intensity of the SAA RT-PCR product over that of the
corresponding cyclophilin RT-PCR product (Log SAA –
Log Cyclophilin). Means were compared by variance anal-
ysis and the Dunnett's t test or Student's t test. Differences
were considered significant if p < 0.05. All statistical eval-
uations were carried out and graphs plotted with Graph-
Pad Prism 4.03 (GraphPad software, Inc., San Diego, CA,
USA).
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